Angela Banks Vice President, Policy Angela Banks is Vice President, Policy for PCMA. Angela joined PCMA by way of UnitedHealth Group where she served as Vice President, External Affairs and was responsible for leading the strategic approach to prescription drug
Pharmacy Benefit Companies Ready to Work with Policymakers on Solutions to Build a More Competitive, Sustainable, and Affordable Prescription Drug Marketplace
(Washington, D.C.) — Today, the Pharmaceutical Care Management Association (PCMA) announced the Virtual PBM Policy Forum 2021, featuring health care, pharmacy benefit managers (PBMs), and pharmaceutical manufacturer industry thought leaders and executives discussing how the public and private sectors are tackling
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is announcing the additions of Angela Banks as Vice President, Policy; Jonathan Buxton as Director, State Affairs; and Peter Fjelstad as Director, State Regulatory and Legal Affairs, as well as new
New Research Paper Demonstrates Declining Biosimilars Prices and Increasing Health Plan Coverage (Washington, D.C.) — Pharmacy benefit managers, PBMs, support the proliferation and use of biosimilars. A robust biosimilar market will increase competition for biologic drugs and provide added choice
Claire Winiarek is Vice President, Policy for PCMA. In this role, she leads the association’s policy development activities in support of the industry’s federal and state legislative and regulatory advocacy efforts. Prior to joining PCMA, Claire served as the Director
Speakers Discuss Pharmacy Benefit Company Innovations, Importance of Protecting Cost Saving Role, and Solutions to Improve Affordability
In its Notice of Proposed Rulemaking for 2019, the Centers for Medicare and Medicaid Services (CMS) has proposed what it characterizes as a clarification of existing policy regarding the requirement that prescription drug plans (PDPs) offer a standard contract to
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today is announcing a new three-part policy platform, supported by America’s pharmacy benefit managers, PBMs, aimed at reducing prescription drug costs by updating Medicare Part D, enhancing competition, and building toward a more value-driven
©2024 PCMA. All Rights Reserved.
